Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLYC-101 in laser skin resurfacing
NCT00656474Phase 2Completed
- Sponsor
- TR Therapeutics
- Start
- Mar 2008
- Primary completion
- Apr 2008
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in surgical wound comparing GLYC-101 with Placebo (2 arms). Primary endpoint: Time to Complete Wound Closure (Epithelialization) at 1 month. Started Mar 2008; status: completed.
02
Drugs
TR-987
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT00656474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656474.